TY - JOUR
T1 - Prognostic factors in non-small cell lung cancer patients with postoperative recurrence following third-generation chemotherapy
AU - Yamazaki, Koji
AU - Sugio, Kenji
AU - Yamanaka, Takeharu
AU - Hirai, Fumihiko
AU - Osoegawa, Atsushi
AU - Tagawa, Tetsuzo
AU - Fukuyama, Seiichi
AU - Wataya, Hiroshi
AU - Seto, Takashi
AU - Ichinose, Yukito
PY - 2010/4/1
Y1 - 2010/4/1
N2 - Aim: To analyse the prognostic factors for patients with non-small cell lung cancer (NSCLC) who underwent cytotoxic chemotherapy with third generation agents or epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) for recurrence. Patients and Methods: Between 1997 and 2005, 479 patients underwent a complete resection for NSCLC. Of these, 112 patients underwent chemotherapy for postoperative recurrence. Results: Median postrecurrence survival time for these 112 patients was 25.6 months. Univariate analysis showed female gender, age younger than 65 years, ECOG performance status of 0-I, never-smoker status, and adenocarcinoma prolonged survival, whereas metastasis to the liver or adrenal gland shortened survival. Multivariate analysis revealed age, performance status, cell type and metastasis to the adrenal gland to be independent prognostic factors. Conclusion: Age, performance status, cell type, and metastasis to the adrenal were independent prognostic factors in NSCLC patients treated with third-generation agents or EGFR-TKI for recurrence.
AB - Aim: To analyse the prognostic factors for patients with non-small cell lung cancer (NSCLC) who underwent cytotoxic chemotherapy with third generation agents or epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) for recurrence. Patients and Methods: Between 1997 and 2005, 479 patients underwent a complete resection for NSCLC. Of these, 112 patients underwent chemotherapy for postoperative recurrence. Results: Median postrecurrence survival time for these 112 patients was 25.6 months. Univariate analysis showed female gender, age younger than 65 years, ECOG performance status of 0-I, never-smoker status, and adenocarcinoma prolonged survival, whereas metastasis to the liver or adrenal gland shortened survival. Multivariate analysis revealed age, performance status, cell type and metastasis to the adrenal gland to be independent prognostic factors. Conclusion: Age, performance status, cell type, and metastasis to the adrenal were independent prognostic factors in NSCLC patients treated with third-generation agents or EGFR-TKI for recurrence.
UR - http://www.scopus.com/inward/record.url?scp=77953795906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953795906&partnerID=8YFLogxK
M3 - Article
C2 - 20530445
AN - SCOPUS:77953795906
SN - 0250-7005
VL - 30
SP - 1311
EP - 1315
JO - Anticancer Research
JF - Anticancer Research
IS - 4
ER -
